CD44 and breast carcinoma: Cancer stem/progenitor cell populations have been isolated in clinical samples of breast cancer tissue that characteristically show a CD44+/CD24–/lin− phenotype [63–67] and also preferentially express other stem cell markers such as nucleostemin and active ALDH-1 [64,68,69].